What Are Retinal Prostheses?

Retinal prostheses are implantable electronic devices designed to partially restore functional vision in patients who have lost sight due to the degeneration of photoreceptor cells in the retina. They are intended primarily for conditions such as retinitis pigmentosa and age-related macular degeneration, in which the photoreceptors (rods and cones) are destroyed or non-functional while the downstream retinal ganglion cells (RGCs) and the optic nerve remain intact and capable of transmitting signals to the visual cortex. A retinal prosthesis bypasses the missing photoreceptors by delivering patterned electrical stimulation directly to surviving retinal cells, producing phosphene perceptions (localized flashes of light) that the patient can interpret as a rudimentary image. The engineering of these devices draws on microelectronics, materials science, biocompatibility research, and neural signal processing.

Implant Placement and Architecture

Retinal prostheses are classified by where the electrode array is placed relative to the retinal layers. Epiretinal implants position the electrode array on the inner surface of the retina, directly adjacent to the ganglion cell layer. The Argus II, developed by Second Sight Medical Products and receiving FDA approval in 2013, was the most widely implanted epiretinal device, featuring a 60-electrode array that received wireless power and data from an external camera-and-transmitter unit worn on glasses. Subretinal implants are placed beneath the retina, between the photoreceptor layer and the retinal pigment epithelium, positioning electrodes closer to the surviving bipolar cells. The Alpha IMS subretinal implant, which received CE marking in 2013, demonstrated improved light perception and basic shape recognition in clinical trials. Suprachoroidal implants occupy a surgical plane between the choroid and the sclera, offering a less invasive approach with lower surgical risk, though at some cost to electrode proximity. A detailed engineering and clinical review of these architectures is available in retinal prostheses research published in Sensors.

Signal Delivery and Neural Interface

The core engineering challenge of retinal prostheses is delivering charge-balanced electrical pulses to retinal neurons without causing electrochemical damage to tissue or electrode degradation over years of implantation. Electrode materials must combine low impedance, high charge injection capacity, and long-term biocompatibility; platinum, iridium oxide (IrOx), and PEDOT (poly(3,4-ethylenedioxythiophene)) coatings are common choices. Miniaturization is the primary route to higher resolution: more electrodes in a given retinal area require smaller electrode diameters, which raises impedance and limits safe charge injection. Photovoltaic prostheses represent an alternative energy delivery strategy, converting ambient or infrared light projected through the eye directly into current at each photodiode pixel; the POLYRETINA device contains more than 10,000 physically independent photovoltaic pixels, substantially increasing spatial resolution compared to first-generation implants. An overview of electronic retinal prosthesis technology, including photovoltaic and electrogenic approaches, is available in PMC research on electronic retinal prostheses.

Visual Outcomes and Comparison with Emerging Therapies

Clinical trials have demonstrated that retinal prostheses provide genuine, if limited, visual benefit. Recipients of the Argus II have shown improved light localization, gross object detection, and, in some cases, reading of high-contrast large print. Visual acuity achieved by current devices, typically in the range of 20/460 to 20/565, remains below legal blindness thresholds, and phosphene quality varies significantly among patients. Retinal prostheses compete and may eventually be combined with gene therapy approaches that restore photoreceptor function and optogenetic techniques that introduce light-sensitive opsins into surviving inner retinal cells, as reviewed in comprehensive studies on restoring sight with retinal prostheses.

Applications

Retinal prostheses have applications in a range of medical and engineering contexts, including:

• Clinical vision rehabilitation for patients with end-stage retinitis pigmentosa who retain functional ganglion cells
• Research platforms for understanding retinal neural coding and the spatial resolution limits of electrical stimulation
• Development of biocompatible neural electrode technologies applicable to cortical and spinal cord implants
• Integration with computer vision systems that preprocess camera input to optimize the spatial pattern delivered to the electrode array